Top compounds associated with response to PSME3


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.067 0.06
mRNA KIN001-260 GDSC1000 pan-cancer AAC -0.059 0.06
mRNA temsirolimus GDSC1000 pan-cancer AAC 0.063 0.06
mRNA tipifarnib CTRPv2 pan-cancer AAC -0.059 0.06
mRNA GSK461364 CTRPv2 pan-cancer AAC 0.06 0.06
mRNA BRD-A02303741:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.072 0.06
mRNA tacrolimus CTRPv2 pan-cancer AAC 0.066 0.06
mRNA gossypol CTRPv2 pan-cancer AAC 0.07 0.06
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.068 0.06
mRNA BRD-K30748066 CTRPv2 pan-cancer AAC 0.24 0.06
Download CSV